Kidney Transplant Rejection Clinical Trial
Official title:
Effectiveness of a Psychological Intervention Focused on Expressive Writing in Patients Undergoing to Kidney Transplant
Kidney transplantation is a replacement treatment for chronic renal failure that improves
quality of life. However, it can be experienced as traumatic in relation to the changes it
entails in terms of lifestyle, redefinition of one's body and social and family role. A
negative personal experience could affect adherence to the treatment, a protective factor in
reducing the risk of organ rejection and mortality. Some studies have shown the effectiveness
of expressive writing in reducing the symptoms and management of the disease in patients
undergoing surgery or suffering from cancer. It is hypothesized that this technique allows
the processing of traumatic events linked to the disease, favoring an improvement in the
expression and emotional regulation skills.
The aim of the present study was to evaluate the effectiveness of a psychological
intervention focused on expressive writing on the post-operative course in patients underwent
to kidney transplantation. Thirty-five patients were recruited at the kidney transplant
center of the Policlinico Umberto I, Rome. The sample was divided into 2 groups: the
psychological intervention focused on expressive writing group and the control group which
carried out a neutral writing task. Each patient filled some self-report questionnaires and
carried out blood analysis, before the operation, the day of discharge and at 3 month
follow-up. The psychological intervention group was expected to have a greater improvement in
the emotional skills, adherence and renal function, and a lower level of healthcare costs
compared to the control group.
Kidney transplantation is a replacement therapy in chronic renal failure which could allow a
better quality of life. However, renal transplantation also represents an emotionally strong
experience, which is associated with feelings of acceptance of the transplanted organ, change
in lifestyle, side effects of pharmacotherapies, anxiety, depression, redefinition of one's
body, as well as one's own social and family role. For these reasons it can be experienced as
a traumatic event and be associated with an unfavorable post-operative course, in particular
with regard to adherence to medical prescriptions and the consequent increase in the
possibility of rejection.
Adherence, in fact, implies the correct management of drugs and the constant and assiduous
presence at pre-established check-ups at the transplant center, taking the required exams and
promptly reporting any complications. In kidney transplant patients, adherence to
immunosuppressive therapies becomes fundamental to reduce the risk of organ rejection or, in
the most extreme cases, the risk of death. Several studies show the importance of adherence
to post-operative course treatment in different types of transplant. Furthermore, it has been
shown that poor levels of adherence, recognized as a risk factor for organ rejection, are
associated with an increase in healthcare costs.
Young age, depression, anxiety and avoidant-type adaptation strategies (eg avoiding the
stressful event) are some of the risk factors of non-adherence in kidney transplant patients.
Also alexithymia (known as the inability to identify and describe emotions), the inability to
regulate intense emotional states, and attachment style, are associated with poor levels of
post-transplant adherence.
Possemato and collaborators (2010), showed the efficacy of an intervention that uses
expressive writing in the reduction of post-traumatic stress symptoms in kidney transplant
patients. This technique seems to be effective also in patients with chronic pathologies and
cancer, in particular in the reduction of symptoms , in the management of disease and
psychophysical symptoms in cancer patients. The ways in which this technique acts are not yet
clear, however it is hypothesized that the externalization and processing of traumatic events
linked to the disease may favor an improvement in the ability to express emotions, and the
reduction of negative thoughts and feelings associated. These studies suggest that using the
technique of expressive writing in kidney transplant patients would allow them to externalize
and process emotions, feelings and thoughts related to illness, transplantation and
consequent changes (constant controls and therapies, sudden life style change, drug therapies
and its effects, physical modifications), and this can favor a mental reorganization of
negative events, a greater expression and emotions regulation, and an improvement in the
interpersonal skills with family members and medical staff. Furthermore, this could be
associated with a greater ability to cope with the consequences and psychophysical changes
following transplantation and encourage greater levels of adherence with effects on the risk
of organ rejection and health costs.
The objective of the study was to verify the effects of the expressive writing, on the
post-operative course, in term of organ rejection, psychological well-being, adherence and
healthcare spending in patients undergoing kidney transplantation.
Thirty-five patients were recruited at the kidney transplant center of the Policlinico
Umberto I, Sapienza University of Rome. Each participant completed an informed consent form.
The sample was divided into two groups in a randomized way. Of the 35 patients, 3 were
excluded for not completing the task, due to logistical problems and due to the hospital
situation, 1 refuse to perform the writing task, and finally 3 dropped to T2 (3rd
post-transplant month). Of the remaining 28, 2 had an acute rejection before starting the
writing task. The final sample is n = 26.
The study had 3 phases:
1. Pre-operative phase (T0)
The time of admission, just before the kidney transplant. In this phase to all
participants were asked socio-demographic information and specific characteristics of
the pathology in progress (eg.duration of dialysis treatment, date of transplantation,
onset of disease). Then, they completed the following self-administered questionnaires:
Beck Depression Inventory (BDI) for the evaluation of depression, State Trait Anxiety
Inventory I and II (STAI Y1 - STAI Y2) for the evaluation of trait and state anxiety,
Toronto Alexythymia Scale 20-item (TAS-20) for assessing the ability to identify and
describe one's emotions, Interpersonal Reactivity index (IRI) for the evaluation of
empathy and the Health Locus of Control for the evaluation of the patient's beliefs on
his state of health and a questionnaire for the evaluation of healthcare costs, built ad
hoc.
To assess the level of adherence, each patient answered to the following question: "Have
you ever forgotten to take drugs prescribed by your treatment plan? "with dichotomous
answer yes / no. Finally, in order to assess the pre-transplant renal function values,
such as Creatinine, CDK-EPI and azotemia were collected.
2. Writing Phase (WP) Five days after the operation, patients belonging to the experimental
group, performed the writing task related to their deepest emotions, thoughts and
concerns focused on the disease and the transplant itself, for 3 consecutive days, for
20 minutes a day. They performed the writing session in a closed and silent room, which
guaranteed their privacy. The instructions were according to the standard delivery by
Pennebaker, creator of the technique, translated and adapted for the specific hospital
situation already proposed in a study on urological patients by Solano et al. (2007).
Instead, the control group performed the neutral writing task, related to the
description of an object in their room, without mentioning emotions, but just describing
in a neutral way what they saw, for 3 consecutive days, 20 minutes each day.
3. The day of discharge Phase (T1) and 4) three months follow up (T2) All participants
filled the questionnaire completed before the operation and they had the blood analysis
according to the hospital protocol for transplanted patients.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT04491552 -
TruGraf® Long-term Clinical Outcomes Study
|
||
Withdrawn |
NCT04560582 -
Immunosuppression Reduction in Failed Allograft Guided by cfDNA
|
||
Completed |
NCT05747274 -
SRDK0921_ Analytical Performance Study
|
||
Not yet recruiting |
NCT05482100 -
CLinical Utility of the omnigrAf® biomarkeR Panel In The Care of kidneY Transplant Recipients
|
||
Recruiting |
NCT06243289 -
Improving KIdney Transplantation With Cellular Therapy Study
|
||
Not yet recruiting |
NCT06025240 -
Expanding the Scope of Post-transplant HLA-specific Antibody Detection and Monitoring in Renal Transplant Recipients
|
||
Completed |
NCT04367610 -
Effects of A Standardized Treatment Approach on Kidney Transplant Recipients With Antibody-Mediated Rejection
|
||
Enrolling by invitation |
NCT06126380 -
Long-Term Safety and Efficacy of Tegoprubart in Kidney Transplant Recipients
|
Phase 2 | |
Terminated |
NCT05747053 -
Personalization of Immunosuppressive Treatment for Organ Transplant Recipients
|
||
Active, not recruiting |
NCT03714113 -
Donor-specific Anti-HLA Antibodies Monitoring in Kidney Transplant Recipients
|
N/A | |
Recruiting |
NCT04091984 -
The PROspera Kidney Transplant ACTIVE Rejection Assessment Registry (ProActive)
|
||
Recruiting |
NCT05335538 -
TruGraf and TRAC In Pediatrics Study
|
||
Completed |
NCT03663335 -
Study of Efficacy, Safety, Tolerability, Pharmacokinetic (PK) and Pharmacodynamic (PD) of an Anti-CD40 Monoclonal Antibody, CFZ533, in Kidney Transplant Recipients
|
Phase 2 | |
Completed |
NCT03652402 -
Precision Risk Stratification in Kidney Transplant Patients - EU-TRAIN
|
||
Recruiting |
NCT04773392 -
Simplified IMmunosuppressive Protocol Utilizing Low Dose EnvarsusXR
|
Phase 4 | |
Terminated |
NCT02974686 -
Conversion From MPA to Zortress (Everolimus) for GI Toxicity Post-renal Transplantation
|
Phase 4 | |
Completed |
NCT03873623 -
The TOGETHER Project - Kidney
|
||
Terminated |
NCT04156204 -
Immunosuppressant Medication Dosed Daily After Kidney Transplant
|
Early Phase 1 | |
Completed |
NCT04601155 -
Transition of Renal Patients Using AlloSure Into Community Kidney Care
|
||
Completed |
NCT03874299 -
The TOGETHER Project - Kidney RNA-seq Validation
|